Reinterventions in patients with congenital aortic stenosis and a commissurotomy

Mostafa Mahmoud1, Bengt Johansson2, Daniel Rinnstrom3

  • 1Public Health and Clinical Medicine, Umeå Universitet, Umea, Sweden.

Open Heart
|March 3, 2025
PubMed

Insights

Most patients undergoing surgical commissurotomy for congenital aortic stenosis (CAS) require reintervention within 30 years. Close follow-up is crucial, as those not needing reintervention showed higher mortality.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiac Surgery

Background:

  • Congenital aortic stenosis (CAS) often necessitates interventions, with commissurotomy as an option for patients unsuitable for valve prostheses.
  • The long-term outcomes and reintervention rates following surgical commissurotomy for CAS are not well-established.
  • This study investigates the need for reinterventions after initial surgical commissurotomy using national registry data.

Purpose of the Study:

  • To determine the cumulative incidence and timing of reinterventions after surgical commissurotomy in patients with CAS.
  • To identify factors associated with reintervention and mortality in this patient cohort.
  • To provide evidence-based recommendations for long-term follow-up strategies.

Main Methods:

  • A national registry of congenital heart diseases (CHDs) was queried for patients diagnosed with CAS and undergoing an index commissurotomy.
  • Follow-up data were analyzed to track reinterventions, mortality, and clinical characteristics such as left ventricular hypertrophy (LVH).
  • Statistical analysis was performed to compare outcomes between patients with and without reinterventions.

Main Results:

  • Out of 300 patients with CAS and index commissurotomy, 54.7% required reintervention, with a median time of 14.2 years post-operation.
  • Cumulative reintervention rates reached approximately 25% at 10 years and 60% at 30 years.
  • Left ventricular hypertrophy (LVH) was more prevalent in patients needing reintervention (41.3% vs. 26.8%), and mortality was higher in those without reintervention (7% cumulative incidence at 30 years).

Conclusions:

  • The majority of patients with CAS undergoing commissurotomy will require subsequent reinterventions, often within 30 years.
  • Higher prevalence of LVH in the reintervention group warrants close monitoring during follow-up.
  • Unexpectedly higher mortality in patients without reintervention underscores the need for continued, vigilant outpatient follow-up after surgical commissurotomy.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...